Cavanaugh Sarah
SEC CIK 1709113 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | SVP of Corp Affairs, Admin | 1,860 | — | $2.51M | 8 | 2021-11-01 | 2024-05-30 |
Most active insiders at CLDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wright Richard M. | Former Off | — | $1.18M |
| 2 | Jimenez Freddy A. | SVP, GC | — | $121.2K |
| 3 | Martin Samuel Bates | SVP AND CFO | — | — |
| 4 | PEPIN RONALD | SVP, CBO | — | — |
Cavanaugh Sarah made no open-market trades at CLDX in the last 12 months.
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-03 | 2024-05-30 | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP OF CORP AFFAIRS, ADMIN | S - Sale+OE | $33.73 | -20.9K | 1,860 | -92% | -$703.4K |
| DM | 2024-06-03 | 2024-05-30 | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP OF CORP AFFAIRS, ADMIN | M - OptEx | $5.80 | +20.9K | 12.6K | New | +$121.0K |
| DM | 2022-08-19 | 2022-08-17+ | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP OF CORP AFFAIRS, ADMIN | M - OptEx | $3.04 | +32.7K | 32.6K | New | +$99.3K |
| DM | 2022-08-19 | 2022-08-17+ | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP OF CORP AFFAIRS, ADMIN | S - Sale+OE | $36.72 | -32.7K | 1,284 | -96% | -$1.20M |
| DM | 2021-12-10 | 2021-12-08 | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs, Admin | M - OptEx | $10.04 | +7,323 | 7,731 | +1,795% | +$73.5K |
| D | 2021-12-10 | 2021-12-08 | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs, Admin | S - Sale+OE | $40.00 | -7,323 | 408 | -95% | -$292.9K |
| DM | 2021-11-03 | 2021-11-01 | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs, Admin | M - OptEx | $8.04 | +5,956 | 7,731 | +336% | +$47.9K |
| DM | 2021-11-03 | 2021-11-01 | CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs, Admin | S - Sale+OE | $43.26 | -7,323 | 3,429 | -68% | -$316.8K |
Purchase Sale Sale after option exercise All abbreviations